HeartMate II LVAS
Device Cardiac Arrhythmias and Heart Failure
General payments
$61,388
Research payments
$2,534
Through program year 2020, $61,388 in general payments and $2,534 in research payments were reported against HeartMate II LVAS (Cardiac Arrhythmias and Heart Failure).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $8,312 | 15 |
| 2020 | Research | $54 | 2 |
| 2019 | General | $53,076 | 213 |
| 2019 | Research | $2,480 | 96 |
Breakdown
The top 5 of 9 recipients; each share is of general payments naming this product in 2020.
Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2020 where a state was reported.
Records
228 general · 98 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.